Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | AMGN | VRTX | GILD | BMY |
| Company | Alexion Pharm Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 181.04 | 320.58 | 473.91 | 89.49 | 54.33 |
| High | 182.67 | 320.58 | 475.48 | 90.71 | 55.77 |
| Low | 180.13 | 314.61 | 469.48 | 89.37 | 54.32 |
| Last | 182.50 | 316.57 | 470.67 | 90.61 | 55.27 |
| Change | +3.05 | -2.65 | -0.45 | +1.10 | +0.95 |
| % Change | +1.70% | -0.83% | -0.10% | +1.23% | +1.75% |
| Volume | 90,506,096 | 608,877 | 318,711 | 2,757,593 | 4,797,540 |
| 20-Day Average Volume | 8,395,359 | 1,644,185 | 1,005,026 | 5,012,071 | 8,435,186 |
| Previous Close | 179.45 | 319.22 | 471.12 | 89.51 | 54.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 319.55 | 476.74 | 87.29 | 53.04 |
| 20-Day Raw Stochastic | 44.63% | 24.19% | 40.08% | 93.20% | 75.87% |
| 20-Day Relative Strength | 55.14% | 43.99% | 47.91% | 69.87% | 61.51% |
| Weighted Alpha | +62.81 | +14.65 | +22.10 | +27.73 | +15.58 |
| Today's Opinion | 72% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 72% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | -0.65% since 10/28/24 | -1.27% since 10/28/24 | +1.70% since 10/28/24 | +4.52% since 10/28/24 |
| Low | 178.51 on 07/19/21 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 86.81 on 10/29/24 | 52.14 on 10/29/24 |
| High | 187.45 on 07/14/21 | 323.40 on 10/31/24 | 478.06 on 10/29/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | -1.42% since 10/04/24 | +3.30% since 10/04/24 | +6.71% since 10/04/24 | +1.96% since 10/04/24 |
| Low | 178.51 on 07/19/21 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 187.45 on 07/14/21 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -5.65% since 08/02/24 | -4.88% since 08/02/24 | +17.58% since 08/02/24 | +12.82% since 08/02/24 |
| Low | 164.83 on 04/29/21 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 187.45 on 07/14/21 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | +1.23% since 05/03/24 | +17.27% since 05/03/24 | +39.34% since 05/03/24 | +25.07% since 05/03/24 |
| Low | 146.97 on 03/04/21 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 187.45 on 07/14/21 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 171,526,160 | 121,597,008 | 111,439,232 | 110,128,096 |
| Shares Outstanding, K | 221,019 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 6,069,900,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | 603,400,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 1,636,500,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | 636,000,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.25 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 07/29/21 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 16.66 | 0.00 | 18.90 | 47.67 |